Bone Mineral and Organic Properties in Postmenopausal Women Treated With Denosumab for Up to 10 years
Sign Up to like & getrecommendations! Published in 2022 at "Journal of Bone and Mineral Research"
DOI: 10.1002/jbmr.4538
Abstract: In postmenopausal women with osteoporosis, denosumab (DMAb) therapy through 10 years resulted in significantly higher degree of mineralization of bone, with a subsequent increase from years 2–3 to year 5 and no further difference between years… read more here.
Keywords: bone; mineral organic; years dmab; maturity ... See more keywords